MSA
CDMO

Marino Stram & Associates’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Marino Stram & Associates’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-639
Closed -$3K – 592
2019
Q1 		$3K Hold
639
– – ﹤0.01% 496
2018
Q4 		$3K Hold
639
– – ﹤0.01% 448
2018
Q3 		$4K Hold
639
– – ﹤0.01% 376
2018
Q2 		$3K Hold
639
– – ﹤0.01% 390
2018
Q1 		$2K Hold
639
– – ﹤0.01% 434
2017
Q4 		$2K Buy
+639
New +$2.74K ﹤0.01% 437

Other funds holding CDMO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marino Stram & Associates's CDMO Position: Q2 2019 in Review

Marino Stram & Associates sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2019, closing a stake of 639 shares — an estimated $3K sold.

Marino Stram & Associates first reported a position in CDMO in Q4 2017 and held it in 6 quarters. The position peaked at $4K in Q3 2018. 98 funds tracked by Wall St. Rank hold CDMO as of Q2 2019.

  • Marino Stram & Associates reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 639 Avid Bioservices, Inc. Common Stock shares in Q2 2019, an estimated $3K.
  • Marino Stram & Associates first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2017 and held it in 6 quarters.
  • Marino Stram & Associates's Avid Bioservices, Inc. Common Stock position peaked at $4K in Q3 2018.
  • 98 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.